Latest Insights on AMZN
The Great Amazon Surveillance Sale
July 17, 2019 Great Stuff
In years past, Amazon.com Inc.’s (Nasdaq: AMZN) Prime Day was an event to look forward to. I love online shopping — I never have to leave my house and deal with crowds and uppity cashiers. So, when the biggest online retailer has a massive two-day sale, it’s like Christmas in July. But this year was […] Friday Four Play: Good Jobs = Bad News
July 5, 2019 Great Stuff
That was quite the Fourth of July celebration, wasn’t it? The fireworks, the music … and stuff. Freedom was everywhere. It was awesome. I don’t know about you, but I’m beat this morning. Apparently, so is the market. But we’ll get to that in a minute. Next week, I’m going on vacation to celebrate my […] Canopy Growth: “Don’t Bring Me Down, Bruce”
July 3, 2019 Great Stuff
Canopy Growth Corp. (NYSE: CGC) has investors running, going out of their minds. Investors are thinking that they’re wasting their time. (Don’t bring me down, no, no, no, no, no.) If you haven’t heard, I’ll tell you once more before I get off the floor. Canopy Growth co-CEO Bruce Linton is out the door. In […] The Trade War Truce Rally: AMD, Apple, Nvidia and Oil?
July 1, 2019 Great Stuff
Today’s G-20 rally is no surprise. There was no way President Donald Trump was coming out of the G-20 meeting without a win — one way or another. And he certainly got a win. I’m not talking about the pause in the trade war — that was a given. It fits Trump’s M.O. to a […] The Real Question for the $63 Billion AbbVie-Allergan Acquisition
June 25, 2019 Great Stuff
I know my brain doesn’t work quite right. I wouldn’t be writing Great Stuff if it did. Today, I’m left with a burning question on AbbVie’s $63 billion cash and stock acquisition of Allergan. It’s not about the viability of the combined company. Both AbbVie Inc. (NYSE: ABBV) and Allergan PLC (NYSE: AGN) face serious […]